Future of Innovation in Oligonucleotide Manufacturing for United States
Decarbonisation of the pharmaceutical sector
Digital Architecture for Real-Time Release Manufacturing
New Oligonucleotide Manufacturing Centre of Excellence with open access — be the first to know about our new GMP oligonucleotide manufacturing innovation capability
SMEs and investors invited to help shape the future of UK MedTech
Coming soon… the UK’s first Oligonucleotide Manufacturing Centre of Excellence: Be the first to know about our new GMP oligonucleotide manufacturing innovation capability
Digital and automation technologies to drive advanced process innovation
Method development for characterisation of AAV
Improving Patient Flow and Discharge Through Digital Innovations
Intracellular drug delivery — High throughput lipid screening and Integrating Adaptive Design of Experiments
